Every material Form 8-K SIGA TECHNOLOGIES INC has filed with the SEC since May 07, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
SIGA Technologies reported second-quarter 2026 results with sharp year-over-year declines: total revenues were $41.0 million versus $81.1 million, and net income was $12.5 million versus $35.5 million. The quarter's deliveries completed the last procurement order under the 19C contract with the U.S. Strategic National Stockpile, and the filing's risk factors cite the need to secure new U.S. Government contracts to maintain or expand the stockpile.
Q2 2026 total revenues were $41.0 million, down from $81.1 million in Q2 2025; product sales were $37.9 million versus $79.1 million.
Q2 2026 net income was $12.5 million, or $0.17 per diluted share, compared with $35.5 million, or $0.49 per diluted share, a year earlier.
Q2 2026 deliveries included $24 million of IV TPOXX to the U.S. strategic national stockpile, completing the last procurement order under the 19C contract.
Cash and cash equivalents were $117.6 million at June 30, 2026, compared with $155.0 million at December 31, 2025.
At its June 9, 2026 annual meeting, SIGA stockholders approved raising the share reserve under the 2010 Stock Incentive Plan from 8,500,000 to 15,000,000 shares. They also elected eight directors, ratified PricewaterhouseCoopers LLP as auditor for 2026, and approved the non-binding advisory vote on executive compensation. The larger reserve gives the company room to grant more equity awards, which would add to shares outstanding.
Plan amendment adds 6,500,000 shares, raising the authorized total under the 2010 Plan from 8,500,000 to 15,000,000 shares; votes were 38,823,234 for, 12,390,841 against and 20,559 abstaining, with 11,201,471 broker non-votes.
Stockholders holding 62,436,105 shares, or 87.05% of shares outstanding as of the April 17, 2026 record date, attended or were represented by proxy.
All eight director nominees were elected, including Jaymie A. Durnan with 45,259,891 votes for and 5,974,743 withheld.
SIGA Technologies reported first-quarter 2026 total revenues of $6.2 million, down from $7.0 million a year earlier, and a net loss of $3.5 million, compared with $0.4 million in the first quarter of 2025. Management said it expects to deliver more than $35 million of oral and IV TPOXX to the U.S. government and an international customer across the second and third quarters of 2026, which is the main near-term revenue driver the company cited.
Total revenues were $6.2 million for the three months ended March 31, 2026, versus $7.0 million a year earlier.
Product sales fell to $3.5 million from $5.8 million, while research and development revenues rose to $2.7 million from $1.2 million.
Net loss was $3.5 million, or $0.05 per diluted share, compared with a net loss of $0.4 million, or $0.01 per diluted share.
About $13 million of oral TPOXX is planned for delivery to an Asia Pacific customer in the second quarter of 2026, and about $26 million of IV TPOXX to the U.S. Strategic National Stockpile by the end of the third quarter.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every SIGA TECHNOLOGIES INC filing is on SEC EDGAR ↗. 8-K briefs of other companies →